Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Cruchaga

Showing results (1-10 of 507) with videos related to

Pageof 51
Sort By:
Med (New York, N.Y.)|May 19, 2022
Integrating functional genomics with genetics to understand the biology of ALS and FTDCarlos Cruchaga
Nature Neuroscience|August 27, 2014
The epigenetic landscape of Alzheimer's diseaseJenny Lord, Carlos Cruchaga
Acta Neuropathologica|February 4, 2014
TMEM106B: a strong FTLD disease modifierYuetiva Deming, Carlos Cruchaga
Acta Neuropathologica|September 18, 2016
Paving the road for the study of epigenetics in neurodegenerative diseasesOscar Harari, Carlos Cruchaga
Nature|April 3, 2015
Cruchaga & Goate replyCarlos Cruchaga, Alison M Goate
Nature|April 3, 2015
Cruchaga & Goate replyCarlos Cruchaga, Alison M Goate
The New England Journal of Medicine|October 18, 2013
TREM2 and neurodegenerative diseaseBruno A Benitez, Carlos Cruchaga,
Frontiers in Genetics|November 13, 2014
Identification of rare variants in Alzheimer's diseaseJenny Lord, Alexander J Lu, Carlos Cruchaga
Genes|August 27, 2021
Advances in Genetic and Molecular Understanding of Alzheimer's DiseaseLaura Ibanez, Carlos Cruchaga, Maria Victoria Fernández
Neuron|July 4, 2014
Alzheimer's disease genetics: from the bench to the clinicCeleste M Karch, Carlos Cruchaga, Alison M Goate
Pageof 51

Showing results (1-10 of 507) with videos related to

Sort By:
Pageof 51
Med (New York, N.Y.)|May 19, 2022
Integrating functional genomics with genetics to understand the biology of ALS and FTDCarlos Cruchaga
Nature Neuroscience|August 27, 2014
The epigenetic landscape of Alzheimer's diseaseJenny Lord, Carlos Cruchaga
Acta Neuropathologica|February 4, 2014
TMEM106B: a strong FTLD disease modifierYuetiva Deming, Carlos Cruchaga
Acta Neuropathologica|September 18, 2016
Paving the road for the study of epigenetics in neurodegenerative diseasesOscar Harari, Carlos Cruchaga
Nature|April 3, 2015
Cruchaga & Goate replyCarlos Cruchaga, Alison M Goate
Nature|April 3, 2015
Cruchaga & Goate replyCarlos Cruchaga, Alison M Goate
The New England Journal of Medicine|October 18, 2013
TREM2 and neurodegenerative diseaseBruno A Benitez, Carlos Cruchaga,
Frontiers in Genetics|November 13, 2014
Identification of rare variants in Alzheimer's diseaseJenny Lord, Alexander J Lu, Carlos Cruchaga
Genes|August 27, 2021
Advances in Genetic and Molecular Understanding of Alzheimer's DiseaseLaura Ibanez, Carlos Cruchaga, Maria Victoria Fernández
Neuron|July 4, 2014
Alzheimer's disease genetics: from the bench to the clinicCeleste M Karch, Carlos Cruchaga, Alison M Goate
Pageof 51